Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
- PublisherMARY ANN LIEBERT, INC
- FrequencyBi-monthly
- FrequencyBi-monthly
- Publisher URL
- Website URL
Topics Covered
Recently Published Papers
FAQs
How frequently is the Monoclonal Antibodies in Immunodiagnosis and Immunotherapy published? 
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is published Bi-monthly.
Who is the publisher of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy?
The publisher of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is MARY ANN LIEBERT, INC.
How can I view the journal metrics of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy on editage?
For the Monoclonal Antibodies in Immunodiagnosis and Immunotherapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy?
The eISSN number is 2167-9436 and pISSN number is 2167-9436 for Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Amino acid, Monoclonal antibody, Sepsis, Western blot, Immunization, Diacylglycerol kinase, Placenta Growth Factor, Flow cytometry, Epidermal growth factor receptor, Lycopene, Antitumor activity, Bispecific antibody, Immune network model, Epitope mapping, Immunohistochemistry, Porcine epidemic diarrhea virus, Immunotherapy, Polyclonal antibodies, Immunotoxin, Diphtheria toxin.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.